NCT03770572: An ongoing trial by Alcyone Therapeutics, Inc
This trial is ongoing. It must report results 4 years, 9 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03770572 |
|---|---|
| Title | Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9 |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 13, 2018 |
| Completion date | Sept. 30, 2029 |
| Required reporting date | Sept. 30, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |